Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Educazione Prenatale Mobile per Futuri Padri e i Suoi Effetti sul Legame, lo Stress, l'Allattamento al Seno e la Soddisfazione Coniugale

2 ottobre 2026 aggiornato da: Sebahat Kuşlu, Gaziantep Islam Science and Technology University

Formazione Prenatale Mobile per i Padri in Attesa e i Suoi Effetti sul Legame, lo Stress, l'Allattamento al Seno e la Soddisfazione Coniugale

The aim of this interventional clinical trial is to assess whether a mobile-based antenatal education programme for expectant fathers has a positive effect on father-infant bonding, stress levels, and breastfeeding attitudes.

The study aims to answer the following main questions:

Does participation in a mobile-based prenatal education programme strengthen fathers' emotional bonds with their babies? Does the education reduce fathers' stress levels during the prenatal and postnatal periods? Does it increase the father's knowledge and supportive attitude towards breastfeeding? Researchers will compare whether there are measurable differences in attachment, stress, and breastfeeding attitudes between the intervention group (fathers receiving mobile-based education) and the control group (fathers receiving standard routine information).

Participants: Will complete pre- and post-intervention questionnaires assessing attachment, stress, and breastfeeding attitudes.

The intervention group will have access to a six-module mobile application covering topics such as infant care, nutrition, sleep routines, health and safety, emotional development, and daily care practices.

The study will be conducted with fathers aged 19-65 who became fathers within the last month and voluntarily agreed to participate.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

This interventional clinical trial aims to evaluate the effectiveness of a mobile-based prenatal education programme designed specifically for expectant fathers. The programme aims to strengthen father-infant bonding, reduce paternal stress levels during the prenatal and early postnatal periods, and enhance fathers' knowledge and supportive attitudes related to breastfeeding.

The study is grounded in the increasing scientific evidence demonstrating that fathers play an important role in maternal-infant health, emotional bonding, family cohesion, and early childhood development. Despite this, fathers frequently receive limited antenatal education and often feel unprepared for infant care, breastfeeding support, and the psychological transition to fatherhood. Mobile health (mHealth) technologies provide accessible, cost-effective, and father-friendly educational opportunities that help reduce participation barriers.

In this trial, participants will be randomly assigned to either an intervention group or a control group. Fathers in the intervention group will have access to a six-module mobile application that offers structured prenatal education. The modules cover infant care, nutrition and feeding, sleep routines, health and safety practices, emotional and social development, and daily care skills. The educational content is designed to support cognitive, emotional, and behavioural readiness for fatherhood and to enhance fathers' confidence in newborn care.

Participants in both groups will complete pre- and post-intervention questionnaires assessing father-infant bonding, stress levels, and breastfeeding attitudes. The intervention group will complete the post-test after engaging with the mobile application, while the control group will receive routine standard information and complete the same assessments during the same time periods. Differences between the two groups will be analysed to determine whether the mobile-based education leads to significant improvements in psychological and behavioural outcomes.

The study will be conducted with fathers aged 19-65 who have become fathers within the past month and who voluntarily agree to participate. Exclusion criteria include lack of smartphone access, inability to use mobile applications, or unwillingness to complete the questionnaires.

This trial is expected to contribute to the development of evidence-based perinatal care interventions that enhance paternal involvement within the domain of women's health nursing, support family-centred care models, and promote practices that strengthen maternal and infant health.

Tipo di studio

Interventistico

Iscrizione (Stimato)

80

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Gaziantep
      • Şahinbey, Gaziantep, Turchia (Türkiye)
        • Gaziantep Islam Science and Technology University
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 19 anni a 65 anni (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Maschio

Descrizione

Inclusion Criteria:

  • Age between 19 and 65 years
  • First-time father
  • Has become a father within the last month
  • Has a healthy newborn without congenital anomalies or chronic illnesses
  • Does not have a premature or low-birth-weight baby
  • Has not become a father through adoption
  • Owns a mobile phone capable of accessing the mobile-based application
  • Has an Android or iOS operating system
  • Has not received any infant care training within the last 6 months
  • Has no physical or mental disability that would prevent viewing, hearing, or understanding the research questions or educational content
  • Voluntarily agrees to participate in the research

Exclusion Criteria:

  • Declines to participate in the research
  • Does not own a smartphone
  • Cannot use mobile applications
  • Has a physical or mental condition that prevents completing the questionnaires
  • Has a baby with congenital anomalies or chronic medical conditions
  • Has a premature or low-birth-weight baby
  • Has received infant care training within the last 6 months
  • Has adopted a child
  • Is outside the 19-65 age range

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Mobile-Based Prenatal Education for Expectant Fathers

Fathers in this arm will receive access to a six-module mobile-based prenatal education programme covering infant care, nutrition and feeding, sleep routines, health and safety practices, emotional and social development, and daily care skills. They will complete pre- and post-intervention questionnaires on father-infant bonding, stress levels, and breastfeeding attitudes.

The intervention is a six-module mobile-based training programme developed specifically for expectant fathers.

The modules cover baby care, nutrition, sleep patterns, health and safety, emotional development and daily care.

The aim is to strengthen the father-baby bond, reduce stress levels and develop a positive attitude towards breastfeeding.

Nessun intervento: Standard Routine Information for Expectant Fathers

Fathers in this arm will receive standard routine information provided in usual care. They will not have access to the mobile-based education programme. They will complete the same pre- and post-intervention questionnaires on father-infant bonding, stress levels, and breastfeeding attitudes during the same time intervals as the intervention group.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Paternal Stress Levels
Lasso di tempo: Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Paternal stress levels measured using the State-Trait Anxiety Inventory (STAI-State Subscale). A total score of 0-19 indicates no anxiety, a total score of 20-39 indicates mild anxiety, a total score of 40-59 indicates moderate anxiety, and a total score of 60-79 indicates severe anxiety. A total score of 60 or above indicates that the individual requires professional help.

Baseline (Day 1) and Post-Intervention (8 weeks after baseline)
Change in Father-Infant Bonding
Lasso di tempo: Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Father-infant bonding measured using the Father-Infant Bonding Scale. High scores on the scale indicate a high level of attachment.

Baseline (Day 1) and Post-Intervention (8 weeks after baseline)
Change in Breastfeeding Attitudes and Participation
Lasso di tempo: Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Fathers' attitudes and participation related to breastfeeding measured using the Fathers' Breastfeeding Attitude and Participation Scale. The total score under the sub-dimension of Fathers' Attitude Towards Breastfeeding ranges from 14 to 70, and the cut-off point for the scale is 58. The total score under the sub-dimension of Fathers' Participation in Breastfeeding ranges from 14 to 70, and the cut-off point for the scale is 58. High scores indicate high attitude and participation.

Baseline (Day 1) and Post-Intervention (8 weeks after baseline)
Change in Marital Satisfaction Levels
Lasso di tempo: Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Marital satisfaction measured using the Marital Satisfaction Scale. The total score that can be obtained from the scale, which consists of a single subscale, ranges from 12 to 60 points. There are no reverse items on the scale. An increase in the score obtained from the scale indicates a high level of marital satisfaction.

Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Investigatore principale: Sebahat Kuşlu, MSc, Gaziantep Islam Science and Technology University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 gennaio 2027

Completamento primario (Stimato)

1 marzo 2027

Completamento dello studio (Stimato)

1 aprile 2027

Date di iscrizione allo studio

Primo inviato

19 novembre 2025

Primo inviato che soddisfa i criteri di controllo qualità

16 dicembre 2025

Primo Inserito (Effettivo)

19 dicembre 2025

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

5 ottobre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

2 ottobre 2026

Ultimo verificato

1 dicembre 2025

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • Ethical Approval: 582.45.13

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

The ethics committee, confidentiality or national legislation deem sharing inappropriate.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .